Tip Sheets

Download patient and health care provider Tip Sheets that provide an overview of eligibility requirements and enrollment steps

Patient Tip Sheets

  • How to Apply for Prescription Products

    Aimovig (erenumab-aooe), Corlanor® (ivabradine) tablets, Enbrel® (etanercept), LUMAKRAS (sotorasib), Prolia® (denosumab) injection for Bone Health, Repatha® (evolocumab), and Sensipar® (cinacalcet) tablets

  • How to Apply for Physician-Administered Products

    Aranesp® (darbepoetin alfa), AVSOLA (infliximab-axxq), EPOGEN® (Epoetin alfa) for dialysis use only, EVENITY™ (romosozumab-aqqg), KANJINTI™ (trastuzumab-anns), Kyprolis® (carfilzomib), MVASI(bevacizumab-awwb), Neulasta® (pegfilgrastim), NEUPOGEN® (Filgrastim), Nplate® (romiplostim), Parsabiv (etelcalcetide), Prolia® (denosumab) injection, RIABNI (rituximab-arrx), Vectibix® (panitumumab) injection, and XGEVA® (denosumab)

  • How to Apply for On Demand Products

    BLINCYTO® (blinatumomab) for injection and IMLYGIC® (talimogene laherparepvec)

Provider Tip Sheets

Amgen Safety Net Foundation does not charge patients a fee for its assistance. Amgen Safety Net Foundation is not affiliated with third parties who charge a fee for assistance with enrollment or medication refills. If you are being charged a monthly fee for support from the Amgen Safety Net Foundation, the organization billing you is not the Amgen Safety Net Foundation and you are being charged for support that the Amgen Safety Net Foundation can provide to you directly at no cost.